---

RMMS Secures Invalidity And Non-Infringement Victories on Patents Related To Axiron® (Testosterone) Transdermal Solution -

---

RMMS Recognized As Second Most Active Firm Representing Defendants in Hatch-Waxman Cases -

---

Federal Circuit Affirms Judgment of Invalidity Concerning OxyContin® (oxycodone extended-release tablets) -